InvestorsHub Logo
Followers 35
Posts 2608
Boards Moderated 0
Alias Born 01/02/2003

Re: Smitty5150 post# 673907

Thursday, 02/22/2024 12:09:33 PM

Thursday, February 22, 2024 12:09:33 PM

Post# of 726236
Very fair poin and I agree they have zero people to run an operating business.
They use the franchise model generally speaking, but the way I see it is nwbo will be an R&D company that collects royalties on DCVax ann Eden’s useage and outsource operations. Yes they need to hire people for sure I’m just not sure how costly that is and the timing of capital needs to meet ramping internal personnel. This is approaching rapidly.
What I think I do know is that they have zero money to ramp up personnel. So that answers the question others can’t answer.
I think it’s very possible they can ramp up personnel as they get non dilutive capital from the Mercks etal for running trials and upfront payments for a piece of the action.
In summary, if they get the right BO price then take it. If they don’t, it’s not too late to ramp personnel.
LP IMO is proceeding with previously planned personnel ramp as approvals come in. I think she also already knows what capital will be coming in and when because deals are already in place contingent on MHRA approval.
After approval, I expect one or more deals but absent any significant ramp I’m with you.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News